The "Father Bull" is unknown but must have been an outstanding Hereford. The double calf was alive and healthy but died during birth. This calf, or calves, joined from the beginning of the neck as far as the belly, with two complete, almost perfect body frames, had but one system of vital organs. Each of the two normal heads had a food channel to one stomach and a breathing channel, or windpipe, to the one set of lungs. The two briskets, or breasts, shared on each side by these calves, contained the one set of lungs on one side and the one heart on the other side. Branching off from the one stomach and digestive system were two channels of elimination. The calf weighed approximately 85 pounds (39 kg) at birth. The over-all measurements as it stands mounted are: 42.5 inches (1,080 mm) high, 20 inches (510 mm) from tail to tail, and 18 inches (460 mm) from side to side including the front legs. The "Mother Cow" lived and was sold as a "fat cow" in July 1949. This calf was stuffed by C. J. Sanders, taxidermist, 2631 South State Street, Salt Lake City 5, Utah, who stated that it is the most unusual monstrosity he has ever worked with. Dr. A. C. Johnson, of Cedar City, Utah, stated that this was the best specimen of monstrosity in animal life that he has ever seen or heard of in his 47 years of practice as a veterinarian.
Levosalbutamol, also known as levalbuterol, is a short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Evidence is inconclusive regarding the efficacy of levosalbutamol versus salbutamol or salbutamol-levosalbutamol combinations, however levosalbutamol is believed to have a better safety profile due to its more selective binding to β2 receptors (primarily in the lungs) versus β1 (primarily in  heart muscle).The drug is the (R)-(−)-enantiomer of its prototype drug salbutamol. It is available in some countries in generic formulations from pharmaceutical companies including Cipla, Teva, and Dey, among others. Medical use
Levosalbutamols bronchodilator properties give it indications in treatment of COPD (chronic obstructive pulmonary disease, also known as chronic obstructive lung disease) and asthma. Like other bronchodilators, it acts by relaxing smooth muscle in the bronchial tubes, and thus shortening or reversing an acute "attack" of shortness of breath or difficulty breathing. Unlike some slower-acting bronchodilators, it is not indicated as a preventative of chronic bronchial constriction. Comparison to salbutamol
A 2013 systematic review of the drugs use as a treatment for acute asthma found that it "was not superior to albuterol regarding efficacy and safety in subjects with acute asthma." The review concluded: "We suggest that levalbuterol should not be used over albuterol for acute asthma." Levalbuterol is notably more costly. Adverse effects
Generally, levosalbutamol is well tolerated.